Cardiovascular risk indicators among depressed persons: A special case?

Elisabeth M van Zutphen1, Almar A L Kok2, Majon Muller3

  • 1Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Psychiatry, De Boelelaan 1117, Amsterdam, the Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Epidemiology and Data Science, De Boelelaan 1117, Amsterdam, the Netherlands; GGZ inGeest Mental Health Care, Amsterdam, the Netherlands; Amsterdam Public Health, Mental Health, Amsterdam, the Netherlands; Amsterdam Public Health, Aging & Later Life, Amsterdam, the Netherlands.

Insights

Depression symptom severity and anxiety indicate higher cardiovascular risk in depressed individuals. However, these factors offer minimal improvement to existing cardiovascular risk prediction models for this population.

Area of Science:

  • Cardiology
  • Psychiatry
  • Epidemiology

Background:

  • Traditional cardiovascular risk factors incompletely explain cardiovascular disease (CVD) risk in depressed individuals.
  • Depression may involve unique risk indicators like symptom severity, insomnia, loneliness, and neuroticism.
  • Limited research exists on the added predictive value of depression-related characteristics for CVD risk.

Purpose of the Study:

  • To investigate whether depression-related characteristics improve cardiovascular risk prediction in depressed adults beyond traditional indicators.
  • To assess the incremental value of specific depression-related factors in predicting incident CVD.

Main Methods:

  • Utilized data from 1028 depressed Dutch adults without prevalent CVD from two longitudinal cohort studies.
  • Assessed medication-confirmed self-reported CVD as the outcome.
  • Included fifteen depression-related characteristics and traditional cardiovascular risk indicators, analyzed using Cox regression and c-statistics for incremental value.

Main Results:

  • During a median 65.3-month follow-up, 12.7% developed CVD.
  • Only anxiety and depressive symptom severity were associated with incident CVD beyond traditional risk factors.
  • Including anxiety or depression severity marginally increased model predictive ability (0.56 or 0.33 percentage points, respectively) from a baseline c-statistic of 85.47%.

Conclusions:

  • Anxiety and depressive symptom severity are associated with increased cardiovascular risk in depressed persons.
  • These factors provide limited incremental value for cardiovascular risk assessment in this population.
  • Existing cardiovascular risk prediction models require validation specifically in depressed individuals.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
396
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
65
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
42
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
312
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
185
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
149